Abrams & Bayliss 'On The Line' In Biogen Fee-Shift Request
Pharmaceutical company Biogen Inc. narrowly avoided a shareholder's demand that it pay for driving up litigation costs in a Delaware Chancery books and records case, but its counsel Abrams & Bayliss...To view the full article, register now.
Already a subscriber? Click here to view full article